Spine StemCells, Inc. Presents Interim Results from its Phase II Pathway Study in Chronic Cervical Spinal Cord Injury at ASIA Annual Meeting byJosh SandbergApril 20, 2016
Neuro Court Rules That StemCells, Inc. Lacks Standing to Pursue Patent Infringement Suit byJosh SandbergJuly 25, 2015
Spine StemCells, Inc. Announces Commencement of the Second Cohort of the Pathway(TM) Study in Cervical Spinal Cord Injury byJosh SandbergJune 5, 2015
